Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
NIHR Journals Library
2010-10-01
|
| Series: | Health Technology Assessment |
| Online Access: | https://doi.org/10.3310/hta14suppl2/06 |